Shopping Cart
- Remove All
Your shopping cart is currently empty
Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $34 | In Stock | |
| 25 mg | $55 | In Stock | |
| 50 mg | $80 | In Stock | |
| 100 mg | $105 | In Stock | |
| 200 mg | $142 | In Stock | |
| 500 mg | $236 | Backorder | |
| 1 mL x 10 mM (in DMSO) | $39 | In Stock |
| Description | Rasagiline (AGN1135) is an inhibitor of monamine oxidase used as adjunctive therapy in combination with levodopa and carbidopa in the management of Parkinsons disease. |
| Targets&IC50 | MAO-A:412 nM, MAO-B:4.43 nM |
| Synonyms | TVP1012, AGN1135 |
| Molecular Weight | 171.24 |
| Formula | C12H13N |
| Cas No. | 136236-51-6 |
| Smiles | C#CCN[C@@H]1CCC2=C1C=CC=C2 |
| Relative Density. | 1.05 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 23.4 mM, Sonication is recommended. DMSO: 50 mg/mL (291.99 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (11.68 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.